Clinical trial · Interventional
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
NCT00310479CI-TRIAL-00021104completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We seek to develop an advanced imaging approach to identifying and localizing prostate cancer. We believe that high field MRI (magnetic resonance imaging) has the potential to do this and we will endeavor to prove this by having patients with prostate cancer pre-operatively undergo a technique called magnetic resonance spectroscopy. After surgery, the microscopic locations of cancer will be compared with the pre-operative images to assess how well the imaging technique succeeds.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Magnetic Resonance Spectroscopy (3Tesla) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- characteristic metabolic pattern of prostate cancer at 3Tesla
Secondary outcomes (2)
- measure
- specificity, accuracy, NPV
- measure
- PPV of MRS in the detection of prostate cancer
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically verified prostate cancer * Patient has opted for surgery * Low risk prostate cancer PSA \<1 0, Gleason \< 7, Stage \< T2b * No contraindication to MR scanning * No prior history of malignancy * Fit for surgery Exclusion Criteria: * Nonbiopsied lesion * Intermediate or high risk prostate cancer * Unfit for surgery * Contraindication to MR scanning (i.e. pacemaker, aneurysm clips, claustrophobia)
References
Publications (0)
Data not yet available
No reference posted for this study.